Endovascular therapy for visceral artery aneurysms

Int Angiol. 2016 Dec;35(6):573-578. Epub 2015 Sep 29.

Abstract

Background: The aim of this study was to report outcome and complications of endovascular therapy for visceral artery aneurysms (VAA).

Methods: Forty endovascular procedures for VAAs were performed in 33 patients between 2009 and 2014.

Results: The main indications was size (N.=15), bleeding (N.=14) and mycotic aneurysm (N.=3). The splenic artery was the most common artery of true aneurysms (11/16) and pseudo aneurysms due to pancreatitis (5/14). The median size of the true aneurysms was 24 mm (range 15-65). Two ruptures of true VAAs occurred in elderly. Five patients had eleven synchronous artery aneurysms at CT abdomen. Local anesthesia was used in 93%. Coil embolization were performed without (N.=15) and with (N.=14) other techniques. Nine aneurysms were excluded with stent grafts and patency rate was 88%. Coil embolization was complicated by five spleen infarctions, managed with splenectomy (N.=1) and drainage of abscess (N.=1). One patient died, unrelated to the VAA.

Conclusions: Endovascular therapy of VAAs, irrespective of etiology, was an effective treatment option.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aneurysm, False / diagnostic imaging
  • Aneurysm, False / therapy*
  • Aneurysm, Infected / diagnostic imaging
  • Aneurysm, Infected / therapy*
  • Blood Vessel Prosthesis Implantation* / adverse effects
  • Computed Tomography Angiography
  • Drainage
  • Embolization, Therapeutic* / adverse effects
  • Endovascular Procedures* / adverse effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Registries
  • Retrospective Studies
  • Risk Factors
  • Splenectomy
  • Sweden
  • Time Factors
  • Treatment Outcome
  • Viscera / blood supply*